Impact of IL-2 and IL-2R SNPs on Proliferation and Tumor-killing Activity of Lymphokine-Activated Killer Cells from Healthy Chinese Blood Donors |
Li, Yan
(Molecular Oncology Department of Cancer Research Institution, The First Affiliated Hospital of China Medical University)
Meng, Fan-Dong (Molecular Oncology Department of Cancer Research Institution, The First Affiliated Hospital of China Medical University) Tian, Xin (Molecular Oncology Department of Cancer Research Institution, The First Affiliated Hospital of China Medical University) Sui, Cheng-Guang (Molecular Oncology Department of Cancer Research Institution, The First Affiliated Hospital of China Medical University) Liu, Yun-Peng (Oncology, The First Affiliated Hospital of China Medical University) Jiang, You-Hong (Molecular Oncology Department of Cancer Research Institution, The First Affiliated Hospital of China Medical University) |
1 |
Ainiding G, Kawano Y, Sato S, et al (2014). Interleukin 2 receptor |
2 | Archimbaud E, Bailly M, Dore JF (1991). Inducibility of lymphokine activated killer (LAK) cells in patients with acute myelogenous leukaemia in complete remission and its clinical relevance. Br J Haematol, 77, 328-34. DOI |
3 | Carr EJ, Clatworthy MR, Lowe CE, et al (2009). Contrasting genetic association of IL2RA with SLE and ANCAassociated vasculitis. BMC Med Genet, 10, 22. |
4 | Bei CH, Bai H, Yu HP, et al (2014). Combined Effects of Six Cytokine Gene Polymorphisms and SNP-SNP Interactions on Hepatocellular Carcinoma Risk in Southern Guangxi, China. Asian Pac J Cancer Prev, 15, 6961-7. 과학기술학회마을 DOI |
5 | Brady J, Carotta S, Thong RP, et al (2010). The interactions of multiple cytokines control NK cell maturation. J Immunol, 185, 6679-88. DOI |
6 | Buckner JH (2010). Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases. Nat Rev Immunol, 10, 849-59. DOI ScienceOn |
7 | Cui Zhou, Song-Song Jiang, Cui-Yan Wang, et al (2014). Different immunology mechanisms of Phellinus igniarius in inhibiting growth of liver cancer and melanoma cells. Asian Pac J Cancer Prev, 15, 3659-65. 과학기술학회마을 DOI |
8 | Chan CJ, Andrews DM, McLaughlin NM, et al (2010). DNAM-1/CD155 nteractionspromote cytokine and NK cell-mediated suppression of poorly immunogenicmelanoma metastases. J Immunol, 184, 902-11. DOI |
9 | Dendrou CA, Plagnol V, Fung E, et al (2009). Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource. Nat Genet , 41, 1011-5. DOI |
10 | Feriazzo G, Moretta L (2014). Dendritic cell editing by natural killer cells. Crit Rev Oncog, 19, 67-75. DOI |
11 | Kelly JM, Darcy PK, Markby JL, et al (2002). Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat Immunol, 3, 83-90. |
12 | Grimm EA, Mazumder A, Zhang HZ, et al (1982). Lymphokineactivated killer cell phenomenon.Lysis of natural killerresistant fresh solid tumor cells by Interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med, 155, 1823-41. DOI ScienceOn |
13 | Hoffmann SC, Stanley EM, Darrin Cox E, et al (2001). Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28- stimulated peripheral blood lymphocytes.Transplantation, 72, 1444-50. DOI |
14 | John S, Turner D, Donn R, et al (1998). Two novel biallelic polymorphisms in the IL-2 gene. Eur J Immunogenet, 25, 419-20. DOI |
15 | Lanier LL, Sun JC (2009). Natural killer cells remember:An evolutionary bridge between innate and adaptive immunity? Eur J Immunol, 39, 2059-64. DOI ScienceOn |
16 | Kimura H, Iizasa T, Ishikawa A, Shingyouji M.Yoshino M, Kimura KM, et al (2008). Prospective phase II study of postsurgical adjuvant chemo-immunotherapy using autologous dendritic cells and activated killer cells from tissue culture of tumor-draining lymph nodes in primary lung cancer patients. Anticancer Res, 28, 1229-38. |
17 | Koh CY, Blazar BR, George T, et al (2001). Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo. Blood, 97, 3132-7. DOI |
18 | Imai K, Matsuyama S, Miyake S, et al (2000). Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence:An 11-year follow-up study of a general population. Lancet, 356, 1795-9. DOI ScienceOn |
19 | Lomonaco E, Tremante E, Cerboni C, et al (2011). Human leukocyteantigen E Contributes to protect tumor cells from lysis by natural killercells. Neoplasia, 13, 822-30. DOI |
20 | Ruggeri L, Mancusi A, Burchielli E, et al (2007). Natural killer cell alloreactivity in a allogeneic hematopoietic transplantation. Curr Opin Oncol, 19, 142-7. DOI |
21 | Lowe CE, Cooper JD, Brusko T, et al (2007). Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat Genet, 39, 1074-82. DOI ScienceOn |
22 | Malek TR (2003). The main function of IL-2 is to promote the development of T regulatory cells. J Leukoc Biol, 74, 961-5. DOI |
23 | Maier LM, Lowe CE, Cooper J, et al (2009). IL-2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. PLoS Genet, 5, 1000322. DOI |
24 | Togawa S, Joh T, Itoh M, et al (2005). Interleukin-2 gene polymorphisms associated with increased risk of gastric atrophy from Helicobacter pylori infection. Helicobacter, 10, 172-8. DOI ScienceOn |
25 | Shubina IZ, Demidov LV, Chikileva IO, et al (2008). LAK immunotherapy in clinical studies. Atlas Effectors of Anti-Tumor Immunity. Springer, 101-10. |
26 | Smyth DJ, Plagnol V, Walker NM, et al (2008). Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med, 359, 2767-77. DOI ScienceOn |
27 | Srivastava S, Lundqvist A, Childs RW (2008). Natural killer cell immunotherapy for cancer:a new hope. Cytotherapy, 10, 775-83. DOI ScienceOn |
28 | Waldmann TA (2006). The biology of interleukin-2 and interleukin-15:Implications for cancer therapy and vaccinedesign. Nat Rev Immunol, 6, 595-601. DOI ScienceOn |
29 | Wang R, Ciardelli TL, Russell JH (1997). Partial signaling by cytokines:Cytokine regulation of cell cycle and Fasdependent, activation-induced death in CD4+subsets. Cell Immunol, 182, 152-60. DOI |
30 | Wang X, Ricker M, Garcia KC (2005). Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gamma receptors. Science, 310, 1159. DOI |
31 | Waldmann H (2006). Immunology:protection and privilege. Nature, 442, 987-8. DOI |
32 | Erhan Aysan, Omer Faruk Bayrak, Esra Aydemir, et al (2013). cancer preventive effects of whole cell type immunization against mice Ehrlich tumors. Asian Pac J Cancer Prev, 14, 3515-9. 과학기술학회마을 DOI |
![]() |